UASt regulatory sequences drive expression of an inverted repeat.
Expression of Ca-P60AGD436 under the control of Scer\GAL4ppl.PP results in smaller lipid droplets in fat cells compared to controls. The relative glyceride level is significantly decreased ro only ~50% of the wild type level.
Adults expressing SERCAGD436 under the control of the cardioblast-specific Scer\GAL4tin.CΔ4 driver show significantly reduced survival on day 6 after a shift to 29[o]C compared to control flies.
Expression under the control of Scer\GAL4Mef2.PR results in early pupal lethality.
Expression of Ca-P60AGD436 under the control of Scer\GAL4elav.PLu results in flies with abnormal wing posture, defective flight behavior and mild locomotion defects.
SERCAGD436, Scer\GAL4ppl.PP has adult fat body phenotype, enhanceable by SeipinGD3208, Scer\GAL4ppl.PP
SERCAGD436, Scer\GAL4ppl.PP has lipid droplet phenotype, enhanceable by SeipinGD3208, Scer\GAL4ppl.PP
SERCAGD436, Scer\GAL4ppl.PP has adult fat body phenotype, non-suppressible by SeipinUAS.EYFP, Scer\GAL4ppl.PP
SERCAGD436, Scer\GAL4ppl.PP has lipid droplet phenotype, non-suppressible by SeipinUAS.EYFP, Scer\GAL4ppl.PP
SERCAGD436, Scer\GAL4ppl.PP is an enhancer of adult fat body phenotype of Scer\GAL4ppl.PP, SeipinGD3208
SERCAGD436, Scer\GAL4ppl.PP is an enhancer of lipid droplet phenotype of Scer\GAL4ppl.PP, SeipinGD3208
Co-expression of SeipinGD3208 and Ca-P60AGD436 under the control of Scer\GAL4ppl.PP further enhances the reduction in lipid droplet size and decrease in glyceride levels seen when either transgene is expressed alone.
Expression of SeipinScer\UAS.T:Avic\GFP-EYFP does not rescue the reduction in lipid droplet size seen in fat body cells when Ca-P60AGD436 is expressed under the control of Scer\GAL4ppl.PP.